Dmitriy Zamarin on Dealing With Side Effects from T-VEC Treatment in Melanoma
Dmitriy Zamarin, MD, PhD, assistant attending physician at Memorial Sloan Kettering Cancer Center, discusses side effects that nurses should look our for when treating patients with the T-VEC virus.
Frontline Olaparib Plus Abiraterone Provides Consistent Clinical Benefit in HRR-Mutated mCRPC
Assessing Subsequent Therapies in mHSPC Confirms OS Benefit From Darolutamide
Long-term Regorafenib Remission in mCRC May Be Linked to ECOG Score, Less Advanced Disease
Abiraterone Plus Prednisone, Apalutamide Improves Prostate Cancer Outcomes Without Impacting HRQoL
2 Commerce Drive Cranbury, NJ 08512